|
1
|
Lazăr DC, Avram MF, Romoșan I, Văcariu V,
Goldiș A and Cornianu M: Malignant hepatic vascular tumors in
adults: Characteristics, diagnostic difficulties and current
management. World J Clin Oncol. 10:110–135. 2019. View Article : Google Scholar
|
|
2
|
Turley EA, Veiseh M, Radisky DC and
Bissell MJ: Mechanisms of disease: Epithelial-mesenchymal
transition-does cellular plasticity fuel neoplastic progression?
Nat Clin Pract Oncol. 5:280–290. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van Tienderen GS, Groot Koerkamp B,
IJzermans JNM, van der Laan LJW and Verstegen MMA: Recreating
tumour complexity in a dish: Organoid models to study liver cancer
cells and their extracellular environment. Cancers (Basel). 11:pii:
E1706. 2019. View Article : Google Scholar
|
|
4
|
Kang M, Sang Y, Gu H, Zheng L, Wang L, Liu
C, Shi Y, Shao A, Ding G, Chen S, et al: Long noncoding RNAs POLR2E
rs3787016 C/T and HULC rs7763881 A/C polymorphisms are associated
with decreased risk of esophageal cancer. Tumour Biol.
36:6401–6408. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Klec C, Gutschner T, Panzitt K and Pichler
M: Involvement of long non-coding RNA HULC (highly up-regulated in
liver cancer) in pathogenesis and implications for therapeutic
intervention. Expert Opin Ther Targets. 23:177–186. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kong X, Duan Y, Sang Y, Li Y, Zhang H,
Liang Y, Liu Y, Zhang N and Yang Q: LncRNA-CDC6 promotes breast
cancer progression and function as ceRNA to target CDC6 by sponging
microRNA-215. J Cell Physiol. 234:9105–9117. 2019. View Article : Google Scholar
|
|
7
|
Ouyang S, Zheng X, Zhou X, Chen Z, Yang X
and Xie M: LncRNA BCAR4 promotes colon cancer progression via
activating Wnt/β-catenin signaling. Oncotarget. 8:92815–92826.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xing Z, Park PK, Lin C and Yang L: LncRNA
BCAR4 wires up signaling transduction in breast cancer. RNA Biol.
12:681–689. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li N, Gao WJ and Liu NS: LncRNA BCAR4
promotes proliferation, invasion and metastasis of non-small cell
lung cancer cells by affecting epithelial-mesenchymal transition.
Eur Rev Med Pharmacol Sci. 21:2075–2086. 2017.PubMed/NCBI
|
|
10
|
Yin XH, Jin YH, Cao Y, Wong Y, Weng H, Sun
C, Deng JH and Zeng XT: Development of a 21-miRNA signature
associated with the prognosis of patients with bladder cancer.
Front Oncol. 9:7292019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu Z, Gao S, Lindberg D, Panja D,
Wakabayashi Y, Li K, Kleinman JE, Zhu J and Li Z: Temporal dynamics
of miRNAs in human DLPFC and its association with miRNA
dysregulation in schizophrenia. Transl Psychiatry. 9:1962019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Angius A, Uva P, Pira G, Muroni MR, Sotgiu
G, Saderi L, Uleri E, Caocci M, Ibba G, Cesaraccio MR, et al:
Integrated analysis of miRNA and mRNA endorses a twenty miRNAs
signature for colorectal carcinoma. Int J Mol Sci. 20:pii: E4067.
2019. View Article : Google Scholar
|
|
13
|
Yen MC, Yeh IJ, Liu KT, Jian SF, Lin CJ,
Tsai MJ and Kuo PL: Next-generation sequencing predicts interaction
network between miRNA and target genes in lipoteichoic
acid-stimulated human neutrophils. Int J Mol Med. 44:1436–1446.
2019.PubMed/NCBI
|
|
14
|
He JH, Li BX, Han ZP, Zou MX, Wang L, Lv
YB, Zhou JB, Cao MR, Li YG and Zhang JZ: Snail-activated long
non-coding RNA PCA3 up-regulates PRKD3 expression by miR-1261
sponging, thereby promotes invasion and migration of prostate cance
cells. Tumour Biol. Oct 14–2016.Epub ahead of print. View Article : Google Scholar
|
|
15
|
Wei H, Pan L, Tao D and Li R: Circular RNA
circZFR contributes to papillary thyroid cancer cell proliferation
and invasion by sponging miR-1261 and facilitating C8orf4
expression. Biochem Biophys Res Commun. 503:56–61. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang F, Mai SR, Cao FP, Cao CX and Zhang
L: MiR-1261/circ-PTPRZ1/PAK1 pathway regulates glioma cell growth
and invasion. Human Cell. 32:540–547. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi YJ and Huo KK: Knockdown expression of
Apc11 leads to cell-cycle distribution reduction in G2/M phase.
Genet Mol Res. 11:2814–2822. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Drouet Y, Treilleux I, Viari A, Léon S,
Devouassoux-Shisheboran M, Voirin N, de la Fouchardière C, Manship
B, Puisieux A, Lasset C and Moyret-Lalle C: Integrated analysis
highlights APC11 protein expression as a likely new independent
predictive marker for colorectal cancer. Sci Rep. 8:73862018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang G, Fang X, Han M, Wang X and Huang Q:
MicroRNA-493-5p promotes apoptosis and suppresses proliferation and
invasion in liver cancer cells by targeting VAMP2. Int J Mol Med.
41:1740–1748. 2018.PubMed/NCBI
|
|
20
|
Xin X, Wu M, Meng Q, Wang C, Lu Y, Yang Y,
Li X, Zheng Q, Pu H, Gui X, et al: Long noncoding RNA HULC
accelerates liver cancer by inhibiting PTEN via autophagy
cooperation to miR15a. Mol Cancer. 17:942018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li R, Zhu H, Yang D, Xia J and Zheng Z:
Long noncoding RNA lncBRM promotes proliferation and invasion of
colorectal cancer by sponging miR-204-3p and upregulating TPT1.
Biochem Biophys Res Commun. 508:1259–1263. 2019. View Article : Google Scholar
|
|
22
|
Francica G and Borzio M: Status of, and
strategies for improving, adherence to HCC screening and
surveillance. J Hepatocell Carcinoma. 6:131–141. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Viveiros P, Riaz A, Lewandowski RJ and
Mahalingam D: Current state of liver-directed therapies and
combinatory approaches with systemic therapy in hepatocellular
carcinoma (HCC). Cancers (Basel). 11:pii: E1085. 2019. View Article : Google Scholar
|
|
24
|
Gao Q, Zhang G, Zheng Y, Yang Y, Chen C,
Xia J, Liang L, Lei C, Hu Y, Cai X, et al: SLC27A5 deficiency
activates NRF2/TXNRD1 pathway by increased lipid peroxidation in
HCC. Cell Death Differ. 27:1086–1104. 2020. View Article : Google Scholar
|
|
25
|
Feld J: Update on the risk of primary and
recurrent HCC With the use of DAA therapy for HCV infection.
Gastroenterol Hepatol (N Y). 15:303–306. 2019.
|
|
26
|
Fang G, Zhang P, Liu J, Zhang X, Zhu X, Li
R and Wang H: Inhibition of GSK-3β activity suppresses HCC
malignant phenotype by inhibiting glycolysis via activating
AMPK/mTOR signaling. Cancer Lett. 463:11–26. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shigeta K, Datta M, Hato T, Kitahara S,
Chen IX, Matsui A, Kikuchi H, Mamessier E, Aoki S, Ramjiawan RR, et
al: Dual programmed death receptor-1 and vascular endothelial
growth factor receptor-2 blockade promotes vascular normalization
and enhances antitumor immune responses in hepatocellular
carcinoma. Hepatology. Aug 5–2019.Epub ahead of print. PubMed/NCBI
|
|
28
|
Ju JX, Zeng QJ, Xu EJ, He XQ, Tan L, Huang
QN, Li K and Zheng RQ: Intraprocedural contrast-enhanced
ultrasound-CT/MR fusion imaging assessment in HCC thermal ablation
to reduce local tumor progression: Compared with routine
contrast-enhanced ultrasound. Int J Hyperthermia. 36:785–793. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mao LH, Chen SY, Li XQ, Xu F, Lei J, Wang
QL, Luo LY, Cao HY, Ge X, Ran T, et al: LncRNA-LALR1 upregulates
small nucleolar RNA SNORD72 to promote growth and invasion of
hepatocellular carcinoma. Aging (Albany NY). 12:4527–4546. 2020.
View Article : Google Scholar
|
|
30
|
Yan D, Jin F and Lin Y: lncRNA HAND2-AS1
inhibits liver cancer cell proliferation and migration by
upregulating SOCS5 to inactivate the JAK-STAT pathway. Cancer
Biother Radiopharm. 35:143–152. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ouyang S, Zhou X, Chen Z, Wang M, Zheng X
and Xie M: LncRNA BCAR4, targeting to miR-665/STAT3 signaling,
maintains cancer stem cells stemness and promotes tumorigenicity in
colorectal cancer. Cancer Cell Int. 19:722019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Godinho MF, Wulfkuhle JD, Look MP,
Sieuwerts AM, Sleijfer S, Foekens JA, Petricoin EF III, Dorssers LC
and van Agthoven T: BCAR4 induces antioestrogen resistance but
sensitises breast cancer to lapatinib. Br J Cancer. 107:947–955.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang H, Yan L, Sun K, Sun X, Zhang X, Cai
K and Song T: lncRNA BCAR4 increases viability, invasion, and
migration of non-small cell lung cancer cells by targeting
glioma-associated oncogene 2 (GLI2). Oncol Res. 27:359–369. 2019.
View Article : Google Scholar
|
|
34
|
Wei Y, Wang Z, Zong Y, Deng D, Chen P and
Lu J: LncRNA MFI2-AS1 promotes HCC progression and metastasis by
acting as a competing endogenous RNA of miR-134 to upregulate FOXM1
expression. Biomed Pharmacother. 125:1098902020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moyret-Lalle C, Drouet Y and Puisieux A:
The catalytic subunit of the anaphase-promoting complex, APC11, is
involved in CIN+ CRC progression. Med Sci (Paris).
35:118–122. 2019.In French. View Article : Google Scholar
|
